Alemtuzumab, a humanized anti-CD52 monoclonal antibody, is used in patients with refractory chronic lymphocytic leukaemia (CLL). We report results in health care with alemtuzumab on consecutive, advanced-stage patients from a well-defined geographical region. Records from 1,301 patients (Stockholm-...
上海玉博生物科技有限公司 主要致力于“PIERCEMA133386Anti-CD52 Monoclonal Antibody100 µg4425 100 µg”的生产销售。多年的“PIERCEMA133386Anti-CD52 Monoclonal Antibody100 µg4425 100 µg”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公
Description:Mouse monoclonal (HI186) antibody to CD52. Specificity:The antibody HI186 reacts with CD52 (CAMPATH-1), a 21-28 kDa glycoprotein containing a large N-linked carbohydrate moiety; mature CD52 molecule is actually much smaller (approx. 8-9 kDa). CD52 is expressed at high levels...
Alemtuzumab, a humanized anti-CD52 monoclonal antibody, was approved by FDA in 2001 for the clinical administration in patients with chronic lymphoblastic leukemia (CLL). Alemtuzumab results in rapid clearance of CD52+ cells by complement-mediated target cell lysis and antibody mediated cellular ...
Anti-CD52 (CAMPATH-1) (Mouse) mAb-PE (Monoclonal Antibody)推荐供应商 我要询价 MEDICAL & BIOLOGICAL LABORATORIES CO., LTD 联系电话:81366846860 电子邮件:MBLname@qq.com CB指数:58 网址:http://www.mblbio.com 相关信息:产品目录(12066)用户评价 ...
Summary Alemtuzumab, a humanized anti‐CD52 monoclonal antibody, is approved for treatment of relapsing multiple sclerosis (MS). In the Phase II/III trials, patients received 12 or 24 mg/day of alemtuzumab in two treatment courses (5 days for course 1 and 3 days for course 2), 12 months...
AntibodySystem由具有30多年蛋白抗体开发经验的 创立于法国,专注于生命科学和生物制药领域研究,总部位于法国斯特拉斯堡市。AntibodySystem自主开发了高效、高产的真核重组表达系统,利用该系统生产了高质量的重组蛋白、抗体产品。目前产品包括药物靶点蛋白以及对照抗体药物、Invivo功能性抗体、SAA系列流式抗体、PEG抗体、磷酸化...
Alemtuzumab(CD52抗体),在85%的病人出现了ADA。原因是CD52广泛表达于APC(DC,单核细胞,记忆B细胞),当他们遇到Alemtuzumab,会将其摄取,递呈给淋巴细胞,诱导ADA的产生。注射Alemtuzumab后,记忆B细胞会出现扩增,是ADA的补充来源。 小编总结 全人源虽然降低了抗体的免疫原性,但是并没有完全解决ADA问题。病人身体状况,遗传...
of circulating lymphocytes in 27 patients with multiple sclerosis by means of a 5-day pulse of the humanised anti-CD52 monoclonal antibody, Campath-1H. ... Coles,J Alasdair,Wing,... - 《Lancet》 被引量: 360发表: 1999年 Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm...
HUMANISED ANTI-CD52 ANTIBODIES 优质文献 相似文献 参考文献Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. METHODS: We depleted 95% of circulating lymphocytes in 27 patients with multiple sclerosis by means of a 5-day pulse of the humanised anti-CD52 ... ...